Journavx Pain Management: FDA Approves New Non-...

By Rene Pretorius

February 19, 2025

The FDA approved Journavx (suzetrigine) oral tablets for the management of moderate to severe acute pain in adults. Journavx pain management is the first drug in a new class of pain management medications. Journa...
Engineered Heart Muscle Allografts Show Promise in Heart Repair
HPV Vaccination Males: Addressing High Infection Rates and Preventing Cervica...
Healthcare at Home: CMC Dubai’s Innovative Program
The Urgent Need for Cancer Screening in South Africa
Improving Cervical Cancer Diagnosis with Nanotechnology in Menstrual Products
Promising Results of Personalized Cancer Vaccine in Renal Cell Carcinoma
Evolving Cervical Cancer Treatment: Innovations and Challenges
Capvaxive Vaccine Approval
South Africa’s Innovative Strategy for Cervical Cancer Prevention
Cost-Effectiveness of Digital HIV Self-Testing
NICE Approves Gene Therapy for Sickle Cell: A Breakthrough in Treatment and H...
Cervical Cancer App: Enhancing Screening and Treatment